HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Living donor liver transplantation for acute liver failure: a 10-year experience in a single center.

AbstractBACKGROUND:
Living donor liver transplantation has become an accepted treatment for various terminal liver diseases.
STUDY DESIGN:
Forty-two living donor liver transplantations performed for acute liver failure during a 10-year period at Kyushu University Hospital were reviewed.
RESULTS:
Causes of liver failure included hepatitis B (n=12), hepatitis C (n=1), autoimmune hepatitis (n=2), Wilson's disease (n=3), and unknown causes (n=24). The graft types were: left lobe (n=33), right lobe (n=8), and lateral segment (n=1). The mean graft volume to standard liver volume ratios were 42.2+/-9.2% in left lobe grafts and 50.5+/-3.9% in right lobe grafts (p < 0.05). Extubation was significantly delayed in grade IV encephalopathy patients (73.7 +/-18.2 hours) compared with patients with other grades (p < 0.01 to grades I and II, p < 0.05 to grade III). All other patients, except one with a subarachnoid hemorrhage, had complete neurologic recovery after transplantation. The 1- and 10-year survival rates were 77.6% and 65.5%, respectively, for grafts, and 80.0% and 68.2%, respectively, for patients.
CONCLUSIONS:
Outcomes of living donor liver transplantation for acute liver failure are fairly acceptable despite severe general conditions and emergent transplant settings. Living donor liver transplantation is now among the currently accepted life-saving treatments of choice for acute liver failure, although innovative medical treatments for this disease entity are still anticipated.
AuthorsToru Ikegami, Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Kensaku Sanefuji, Hiroto Kayashima, Mitsuo Shimada, Yoshihiko Maehara
JournalJournal of the American College of Surgeons (J Am Coll Surg) Vol. 206 Issue 3 Pg. 412-8 (Mar 2008) ISSN: 1879-1190 [Electronic] United States
PMID18308209 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Cohort Studies
  • Female
  • Graft Survival
  • Hepatic Encephalopathy (etiology)
  • Hospitals, University
  • Humans
  • Infant
  • Japan
  • Liver Failure, Acute (etiology, mortality, surgery)
  • Liver Transplantation
  • Living Donors
  • Male
  • Middle Aged
  • Survival Rate
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: